These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2752202)

  • 21. "Chasing the Dragon": A Fatal Case Report of Toxic Leucoencéphalopathie Due to Inhaled Heroin.
    Ochoa-Orozco SA; Gutiérrez-Segura JC; Coral-Leiton AM; Trejos-Orozco EA; Gutiérrez-Sanjuán ÓI; Carvajal-Guevara JD
    Rev Colomb Psiquiatr (Engl Ed); 2020; 49(4):289-292. PubMed ID: 33328022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients.
    Rook EJ; van Ree JM; van den Brink W; Hillebrand MJ; Huitema AD; Hendriks VM; Beijnen JH
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):86-96. PubMed ID: 16433897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chasing the dragon--neurological toxicity associated with inhalation of heroin vapour: case report.
    Hill MD; Cooper PW; Perry JR
    CMAJ; 2000 Jan; 162(2):236-8. PubMed ID: 10674060
    [No Abstract]   [Full Text] [Related]  

  • 24. Hippocampal involvement due to heroin inhalation--"chasing the dragon".
    Gupta PK; Krishnan PR; Sudhakar PJ
    Clin Neurol Neurosurg; 2009 Apr; 111(3):278-81. PubMed ID: 18977583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chasing the dragon: experience in Ireland and association with "Ecstasy".
    Gervin M; Smith R; Bamford L; Keenan E
    Addiction; 1998 Apr; 93(4):601-3. PubMed ID: 9696617
    [No Abstract]   [Full Text] [Related]  

  • 26. Reversible parkinsonism following heroin pyrolysate inhalation is associated with tetrahydrobiopterin deficiency.
    Heales S; Crawley F; Rudge P
    Mov Disord; 2004 Oct; 19(10):1248-51. PubMed ID: 15390004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroimaging features of heroin inhalation toxicity: "chasing the dragon".
    Keogh CF; Andrews GT; Spacey SD; Forkheim KE; Graeb DA
    AJR Am J Roentgenol; 2003 Mar; 180(3):847-50. PubMed ID: 12591709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First use of heroin: changes in route of administration over time.
    Strang J; Griffiths P; Powis B; Gossop M
    BMJ; 1992 May; 304(6836):1222-3. PubMed ID: 1515792
    [No Abstract]   [Full Text] [Related]  

  • 29. Leukoencephalopathy from "chasing the dragon".
    Halloran O; Ifthikharuddin S; Samkoff L
    Neurology; 2005 May; 64(10):1755. PubMed ID: 15911804
    [No Abstract]   [Full Text] [Related]  

  • 30. Toxic leukoencephalopathy after heroin abuse without heroin vapor inhalation: MR imaging and clinical features in three patients.
    Blasel S; Hattingen E; Adelmann M; Nichtweiß M; Zanella F; Weidauer S
    Clin Neuroradiol; 2010 Mar; 20(1):48-53. PubMed ID: 20229208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Chasing the dragon"--imaging of heroin inhalation leukoencephalopathy.
    Hagel J; Andrews G; Vertinsky T; Heran MK; Keogh C
    Can Assoc Radiol J; 2005 Oct; 56(4):199-203. PubMed ID: 16419370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Decrease in the annual frequency of infectious endocarditis among intravenous drug users in southern Spain].
    Torres-Tortosa M; Rivero A; de Alarcón A; Vergara A; Lozano F; Reguera JM
    Enferm Infecc Microbiol Clin; 2000; 18(6):293-4. PubMed ID: 11075491
    [No Abstract]   [Full Text] [Related]  

  • 33. Transaminase abnormalities in intravenous users, smokers and sniffers of heroin.
    Rosenthal SL
    Am J Gastroenterol; 1974 Mar; 61(3):201-5. PubMed ID: 4825955
    [No Abstract]   [Full Text] [Related]  

  • 34. [Bronchospasm from heroin inhalation].
    Izquierdo Patrón M; Martínez-Moratalla J; González Valladeres G
    An Med Interna; 2001 Mar; 18(3):165. PubMed ID: 11594188
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans.
    Comer SD; Collins ED; MacArthur RB; Fischman MW
    Psychopharmacology (Berl); 1999 Apr; 143(4):327-38. PubMed ID: 10367549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Not "Is it treatment?" but "Does it work?".
    Kalant H
    Addiction; 2001 Apr; 96(4):560-2; discusion 564-5. PubMed ID: 11345077
    [No Abstract]   [Full Text] [Related]  

  • 37. [Severe infections in addicts to heroin administered intravenously].
    Martínez JM; de Zárate O; Fernández Bilbao J; Robador Azcarrate A; Montejo Baranda M; González de Zárate Apiñaniz P; Aguirre Errasti C
    Med Clin (Barc); 1984 Oct; 83(13):562-3. PubMed ID: 6513643
    [No Abstract]   [Full Text] [Related]  

  • 38. Deuterodiacetylmorphine as a marker for use of illicit heroin by addicts in a heroin-assisted treatment program.
    Klous MG; Rook EJ; Hillebrand MJ; van den Brink W; van Ree JM; Beijnen JH
    J Anal Toxicol; 2005 Sep; 29(6):564-9. PubMed ID: 16168180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of psychopathology and the relationship between routes of drug administration and psychiatric symptoms in heroin addicts.
    Wang QL; Liu ZM
    Subst Abus; 2012; 33(2):130-7. PubMed ID: 22489585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Thrombocytopenia associated with the endovenous administration of heroin].
    Curull Serrano V; Vilaseca Momplet J; Arnau de Bolós JM; Ribera Crusafont A; Bacardí Noguera R
    Med Clin (Barc); 1983 Oct; 81(11):500. PubMed ID: 6686274
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.